GlassScriptPhysician profile
Susan L Bock
NPI 1861496689
$1,789.02
in general payments reported to CMS, 2019-2025
18 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $458 · 2023: $415 · 2024: $330 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,200.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $541.14 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $312.72 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $219.85 | 2022-2024 | Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.79 | 2022-2025 | Jardiance |
| Teva Pharmaceuticals USA, INC. | $108.30 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $73.75 | 2023-2024 | Gvoke Hypopen |
| Pfizer INC. | $59.62 | 2021 | |
| Lilly USA, LLC | $47.35 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.74 | 2023 | Lifevest |
| Ultragenyx Pharmaceutical INC. | $38.92 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $32.56 | 2024 | Xarelto |
| Mylan Specialty L.P. | $32.32 | 2024 | Yupelri |
| Alkermes, INC. | $22.82 | 2024 | Vivitrol |
| Bayer Healthcare Pharmaceuticals INC. | $21.75 | 2022 | |
| Corcept Therapeutics | $20.07 | 2025 | Korlym |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $18.47 | 2025 | The Cologuard Plus Collection Kit |
| Philips North America LLC | $17.87 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $14.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Bock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.